Pharmstandard Acquires 100% Stake in JSC “LEKKO”

Pharmstandard is one of the largest manufacturers of pharmaceutical products in Russia, finalized its acquisition of 100% voting shares of  «LEKKO» CJSC. According to Elena Archangelskaya, the Financial Director of Pharmstandard, the Company was ready to allocate up to 100 million dollars to complete the merger, however, the cost of merger did not exceed 85 million dollars.

Pharmstandard OJSC placed the bid to acquire ‘Lekko’ in July, 2012, and in September, 6, Russia’s Federal Antimonopoly Service (FAS) granted the approval for the transaction. 

(0 COMMENTS) | SEE MORE »
Share |
DJIA® 12 811.32 +0.00 (0.00%)
Nasdaq 2 895.59 +0.00 (0.00%)
S&P 500 1 377.51 +0.00 (0.00%)
Shanghai 2 068.25 -3.26 (0.16%)
Nikkei 225 8 757.60 -79.55 (0.90%)
Hang Seng 21 430.34 -136.57 (0.63%)
FTSE 100 5 776.05 +0.00 (0.00%)
CAC 40 3 407.68 +0.00 (0.00%)
RTSI 1 409.67 -0.60 (0.04%)
MICEX 1 408.02 +0.23 (0.02%)
USD/RUB 31.51 +0.21 (0.68%)
EUR/RUB 40.22 -0.06 (0.14%)
EUR/USD 1.28 -0.01 (0.81%)
GBP/USD 1.60 -0.00 (0.27%)
OUR CLIENTS